Abstract
Initial reports have suggested that COVID-19 SARS 2 virus is more prevalent and is associated with increased severity in people with diabetes.1 In a recent large series from the USA, diabetes mellitus was present as a comorbidity in over a third of patients hospitalized with COVID-19.2 In a study of 658 hospitalized patients with confirmed COVID-19, three developed diabetic ketoacidosis (DKA).3 Clinical experience during the COVID-19 crisis suggests that DKA and hyperglycaemic hyperosmolar syndrome (HHS) are common in people with COVID-19 infection, and are associated with significant insulin resistance, dehydration and acute kidney injury.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Diabetic medicine : a journal of the British Diabetic Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
